CLINICAL_TRIALS
trial_result
· 2022-02-09
Clinical Trial Update: Pilot Study of Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease [Phase 2]
Summary
Phase 2 pilot trial evaluating fundamental modification of the gut microbiota for refractory Crohn's disease has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Children's Hospital of Philadelphia | Conditions: Crohn Disease | Phase 2 | Status: COMPLETED | Results posted: 2022-02-09